Month: July 2020

NICHT ZUR VERTEILUNG AN NACHRICHTENAGENTUREN DER VEREINIGTEN STAATEN ODER ZUR VERBREITUNG IN DEN VEREINIGTEN STAATENVANCOUVER, British Columbia, Kanada, July 13, 2020 (GLOBE NEWSWIRE) — Euro Manganese Inc. (TSX-V/ASX: EMN) (das „Unternehmen“ oder „EMN“) gibt bekannt, dass die erste Tranche der am 06. Juli 2020 angekündigten Privatplatzierung (das „Angebot“) am 09. Juli 2020 abgeschlossen wurde.Die erste Tranche des Angebots umfasste 5.155.738 Stammaktien („Aktien“) und 16.344.262 CHESS Depositary Interests („CDIs“, wobei jedes CDI einer Aktie entspricht) zu einem Preis von jeweils 0,061 CAD pro Aktie und 0,065 AUD pro CDI mit einem Gesamtbruttoerlös von 1.311.500 CAD.Die zweite Tranche des Angebots, die aus 6.823.944 Aktien zu einem Preis von 0,061 CAD pro Aktie sowie 34.801.343 CDIs zu einem Preis von 0,065 AUD pro CDI besteht,...

VANCOUVER, British Columbia, July 13, 2020 (GLOBE NEWSWIRE) — Westhaven Gold Corp. (TSX-V:WHN) reports that the halt in the trading of its common shares on Friday, July 9, 2020 was requested due to delays in the receipt of eligibility for the new CUSIP related to the name change. The CUSIP has since been made eligible  and the shares will resume trading on Monday, July 13, 2020 under the new CUSIP number 9603501060. The Company’s symbol remains unchanged.Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.On behalf of the Board of DirectorsWESTHAVEN GOLD CORP.About Westhaven:Westhaven is a gold-focused exploration company advancing the high-grade discovery on the Shovelnose project...

ST. LOUIS, July 13, 2020 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced a publication in the European Heart Journal highlighting the benefits of Stereotaxis’ robotic technology in a COVID-19 patient.The publication concludes that catheter ablation “should be performed preferably with a remote navigation system in order to minimize the infectious risk of the staff of the electrophysiology laboratory.”Dr. Giovanni Forleo and colleagues at Luigi Sacco Hospital at the University of Milan presented the case of a 68-year-old patient diagnosed with COVID-19 who was admitted to the emergency department with multiple episodes of sustained ventricular tachycardia and electrical storm. COVID-19 has been associated with cardiovascular...

COS COB, Conn., July 13, 2020 (GLOBE NEWSWIRE) — Chicken Soup for the Soul Entertainment Inc. (Nasdaq: CSSE) (the “Company”), one of the largest operators of streaming advertising-supported video-on-demand (AVOD) networks, today announced the pricing of its underwritten public offering of an aggregate principal amount of $21 million 9.5% Notes due 2025 (“Notes”). In addition, the Company has granted the underwriters a 30-day option to purchase up to $3.15 million of additional Notes to cover overallotments, if any. The Notes will be issued in minimum denominations of $25.00 and integral multiples of $25.00. The offering is expected to close on or about July 17, 2020. The Notes are expected to begin trading on Nasdaq under the symbol “CSSEN” within 30 days of the original issue date. The Notes will not be convertible into or exchangeable...

OMAHA, Neb., July 13, 2020 (GLOBE NEWSWIRE) — Intrado Corporation (“Intrado” or the “Company”), a global leader in technology-enabled services, today announced that Eula Adams has been elected to its board of directors.Mr. Adams is CEO of Neuromonics, Inc., a medical device company providing standalone and cloud based software and hardware solutions for the treatment of tinnitus. He joined Neuromonics after serving as President and COO of Xcore Corporation, a computer hardware design, assembly, and distribution company. He has an extensive background in executive leadership of large, diverse organizations including positions that have included Chief Operating Officer of Pay By Touch and Western Union, and president of numerous divisions of First Data, now part of Fiserv.“Eula has a strong background in technology, operations, and...

ANDOVER, Mass., July 13, 2020 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of technologies that enable advanced processes and improve productivity, today announced that the Company will release second quarter 2020 financial results after market close on Wednesday, July 29, 2020. A conference call with management will be held on Thursday, July 30, 2020 at 8:30 a.m. (Eastern Time). To participate in the conference call, please dial (877) 212-6076 for domestic callers and (707) 287-9331 for international callers, and an operator will connect you.  Participants will need to provide the operator with the Conference ID of 1428938, which has been reserved for this call. Participants are asked to dial in at least 15 minutes in advance to ensure a timely connection to the call.  A live and archived webcast of...

New York, July 13, 2020 (GLOBE NEWSWIRE) — Grayscale Investments, the largest digital currency asset manager, today announced that its Chief Executive Officer and Founder, Barry Silbert, will be featured on an investor call on Thursday, July 16, 2020 at 1:00 PM Eastern Daylight Time. Marissa Arnold press@grayscale.co

CALGARY, Alberta, July 13, 2020 (GLOBE NEWSWIRE) — Eguana Technologies Inc. (the “Company”) (TSX-V:EGT) (OTCQB:EGTYF), announced today that the board of directors has granted incentive stock options to acquire up to an aggregate of 2,305,000 common shares at a strike price of $0.15 per share. Of the options granted, 1,175,000 have been granted to directors and officers of the Company and the remainder to employees.The incentive stock options represent the 2020 annual grant. The options vest in three equal tranches with the first tranche to vest immediately and the remainder over two years with an expiry of July 15, 2030. The grant of the options is subject to the terms of the Stock Option Plan and the approval of the TSX Venture Exchange.About Eguana Technologies Inc.Based in Calgary, Alberta Canada, Eguana Technologies Inc. (EGT:...

SAN DIEGO, July 13, 2020 (GLOBE NEWSWIRE) — Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation therapies that target genetic drivers of cancer, today announced the appointment of Andrew Partridge as executive vice president and chief commercial officer, effective today. Mr. Partridge has more than 20 years of global pharmaceutical sales and marketing experience leading more than 20 commercial launches across multiple indications, including oncology, hematology and rare diseases.“As we progress our global registrational study of repotrectinib and with three other earlier stage drug candidates in our pipeline, I am pleased to have a commercial veteran of Andy’s caliber to lead our market planning and commercialization efforts,” said Dr. Athena Countouriotis, president and chief...